LYTIR

Insider · SEC Form 4 · President & Immunovant CEO

Eric Venker

Filed with the SEC as Venker Eric; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $49.9M of ROIV, IMVT. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $49.9M in total.Jun: Insider sales $6.6MJul: Insider sales $7.1MAug: Insider sales $7.2MSep: Insider sales $7.3MOct: Insider sales $14.5MNov: Insider sales $7.3MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $49.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. ROIVSold: Roivant Sciences Ltd. Nov 3, 2026 200,000 shares filed Nov 5, 2026 999,154 shares held directly after, as filed 10b5-1 plan filing $7.3M
  2. ROIVSold: Roivant Sciences Ltd. Oct 28, 2026 200,000 shares filed Oct 30, 2026 1,199,154 shares held directly after, as filed 10b5-1 plan filing $7.3M
  3. ROIVSold: Roivant Sciences Ltd. Oct 20, 2026 200,000 shares filed Oct 22, 2026 2 transactions 10b5-1 plan filing $7.0M
  4. IMVTSold: Immunovant, Inc. Oct 2, 2026 3,506 shares filed Oct 5, 2026 257,075 shares held directly after, as filed filing $120K
  5. ROIVSold: Roivant Sciences Ltd. Sep 30, 2026 200,000 shares filed Oct 2, 2026 1,599,154 shares held directly after, as filed 10b5-1 plan filing $7.3M
  6. ROIVSold: Roivant Sciences Ltd. Aug 28, 2026 200,000 shares filed Sep 1, 2026 2 transactions 10b5-1 plan filing $7.2M
  7. ROIVSold: Roivant Sciences Ltd. Jul 27, 2026 200,000 shares filed Jul 29, 2026 1,613,063 shares held directly after, as filed 10b5-1 plan filing $7.0M
  8. IMVTSold: Immunovant, Inc. Jul 2, 2026 3,092 shares filed Jul 6, 2026 254,280 shares held directly after, as filed filing $119K
  9. ROIVSold: Roivant Sciences Ltd. Jun 24, 2026 200,000 shares filed Jun 26, 2026 2 transactions 10b5-1 plan filing $6.6M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • ROIV: option exercise or conversion (code M), 4 entries, Jun 24 to Sep 30, 2026
  • IMVT: disposed of to the company (code D), 2 entries, Jul 1 to Oct 1, 2026
  • IMVT: option exercise or conversion (code M), 2 entries, Jul 1 to Oct 1, 2026
  • ROIV: shares withheld for tax or exercise price (code F), 1 entry, Aug 20, 2026
Code D
Shares disposed of to the company itself, such as shares the company took back.
Code F
Shares paid to, or withheld by, the company to cover an exercise price or the tax due on an award.
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.